BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mirza S, Clay RD, Koslow MA, Scanlon PD. COPD Guidelines: A Review of the 2018 GOLD Report. Mayo Clin Proc. 2018;93:1488-1502. [PMID: 30286833 DOI: 10.1016/j.mayocp.2018.05.026] [Cited by in Crossref: 128] [Cited by in F6Publishing: 173] [Article Influence: 42.7] [Reference Citation Analysis]
Number Citing Articles
1 Deniel G, Cour M, Argaud L, Richard JC, Bitker L. Early antibiotic therapy is associated with a lower probability of successful liberation from mechanical ventilation in patients with severe acute exacerbation of chronic obstructive pulmonary disease. Ann Intensive Care 2022;12. [DOI: 10.1186/s13613-022-01060-2] [Reference Citation Analysis]
2 Xu J, Sun X, Zhu H, Cao Y, Pudasaini B, Yang W, Liu J, Guo J. Long-term variability of impulse oscillometry and spirometry in stable COPD and asthma. Respir Res 2022;23:262. [PMID: 36131305 DOI: 10.1186/s12931-022-02185-5] [Reference Citation Analysis]
3 Huang Y, Ding K, Dai Z, Wang J, Hu B, Chen X, Xu Y, Yu B, Huang L, Liu C, Zhang X. The Relationship of Low-Density-Lipoprotein to Lymphocyte Ratio with Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2022;17:2175-85. [PMID: 36106158 DOI: 10.2147/COPD.S369161] [Reference Citation Analysis]
4 Chen Z, Zha L, Ma X, Xu J, Huang D, Wu W, Chen L, Yang F, Liao W, Wang W. Serum Creatinine/Cystatin C Ratio as a Predictor of In-hospital Mortality in Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Lung. [DOI: 10.1007/s00408-022-00568-5] [Reference Citation Analysis]
5 Luo X, Yu S, Zeng Z, Zhou X, Liu Y, Wang L, Hu J, Chang Y. Systemic glucocorticoid prescriptions pattern and factors of inappropriate use in primary care institutions of Southwest China. Front Public Health 2022;10:952098. [DOI: 10.3389/fpubh.2022.952098] [Reference Citation Analysis]
6 Ma L, Gao M. Analysis of Clinical Characteristics and Risk Factors for Drug Resistance in Newly-Treated Patients with Pulmonary Tuberculosis Complicated with Chronic Obstructive Pulmonary Disease. Infect Drug Resist 2022;15:4861-9. [PMID: 36045874 DOI: 10.2147/IDR.S358121] [Reference Citation Analysis]
7 Avian C, Mahali MI, Putro NAS, Prakosa SW, Leu JS. Fx-Net and PureNet: Convolutional Neural Network architecture for discrimination of Chronic Obstructive Pulmonary Disease from smokers and healthy subjects through electronic nose signals. Comput Biol Med 2022;148:105913. [PMID: 35940164 DOI: 10.1016/j.compbiomed.2022.105913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Gong Y, Lin C, Jin Y, Chen R, Melani AS. The Efficacy and Cost-Effectiveness of Umeclidinium/Vilanterol versus Tiotropium in Symptomatic Patients with Chronic Obstructive Pulmonary Disease. Canadian Respiratory Journal 2022;2022:1-12. [DOI: 10.1155/2022/2878648] [Reference Citation Analysis]
9 Weiss JR, Serdenes R, Madtha U, Zhao H, Kim V, Lopez-pastrana J, Eakin MN, O’toole J, Cooper CB, Woodruff P, Kanner RE, Krishnan JA, Iyer AS, Couper D, Morrison MF. Association Between COPD Severity, Exacerbation Risk, and Anxiety and Depression Symptoms in the SPIROMICS Cohort. Journal of the Academy of Consultation-Liaison Psychiatry 2022. [DOI: 10.1016/j.jaclp.2022.07.008] [Reference Citation Analysis]
10 Liu W, Zhu M, Xia L, Yang X, Huang P, Sun Y, Shen Y, Ma J, Chen G. Transnasal High-Flow Oxygen Therapy versus Noninvasive Positive Pressure Ventilation in the Treatment of COPD with Type II Respiratory Failure: A Meta-Analysis. Computational and Mathematical Methods in Medicine 2022;2022:1-10. [DOI: 10.1155/2022/3835545] [Reference Citation Analysis]
11 Ma H, Zhang Q, Zhao Y, Zhang Y, Zhang J, Chen G, Tan Y, Zhang Q, Duan Q, Sun T, Qi C, Li F. Molecular and Clinicopathological Characteristics of Lung Cancer Concomitant Chronic Obstructive Pulmonary Disease (COPD). Int J Chron Obstruct Pulmon Dis 2022;17:1601-12. [PMID: 35860812 DOI: 10.2147/COPD.S363482] [Reference Citation Analysis]
12 Hua Q, Chen G, Yang Y, Leng S, Zhao Z, Bai F, Hu X, Qiu L, Yu Z, Zhang H, Shi J, Dai Q. Quantitative Evaluation of Chronic Obstructive Pulmonary Disease and Risk Prediction of Acute Exacerbation by High-Resolution Computed Tomography. Evid Based Complement Alternat Med 2022;2022:6015766. [PMID: 35865341 DOI: 10.1155/2022/6015766] [Reference Citation Analysis]
13 Lv M, Qiang L, Wang B, Zhang Y, Li Z, Li X, Jin L, Jin S. Complex Evaluation of Surfactant Protein A and D as Biomarkers for the Severity of COPD. COPD 2022;Volume 17:1537-52. [DOI: 10.2147/copd.s366988] [Reference Citation Analysis]
14 Pailhoriès H, Herrmann JL, Velo-Suarez L, Lamoureux C, Beauruelle C, Burgel PR, Héry-Arnaud G. Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome. Eur Respir Rev 2022;31:210259. [PMID: 35613743 DOI: 10.1183/16000617.0259-2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Xue W, Ma J, Li Y, Xie C, Lu H. Role of CD4+ T and CD8+ T Lymphocytes-Mediated Cellular Immunity in Pathogenesis of Chronic Obstructive Pulmonary Disease. Journal of Immunology Research 2022;2022:1-9. [DOI: 10.1155/2022/1429213] [Reference Citation Analysis]
16 Yang CX, Tomchaney M, Landecho MF, Zamacona BR, Marin Oto M, Zulueta J, Malo J, Knoper S, Contoli M, Papi A, Vasilescu DM, Sauler M, Straub C, Tan C, Martinez FD, Bhattacharya D, Rosas IO, Kheradmand F, Hackett TL, Polverino F. Lung Spatial Profiling Reveals a T Cell Signature in COPD Patients with Fatal SARS-CoV-2 Infection. Cells 2022;11:1864. [PMID: 35740993 DOI: 10.3390/cells11121864] [Reference Citation Analysis]
17 Song X, Hallensleben C, Shen H, Zhang W, Gobbens RJJ, Chavannes NH, Versluis A. REducing delay through edUcation on eXacerbations for people with chronic lung disease: Study protocol of a single-arm pre-post study. J Adv Nurs 2022. [PMID: 35621365 DOI: 10.1111/jan.15311] [Reference Citation Analysis]
18 Rahman HH, Niemann D, Munson-McGee SH. Urinary metals, arsenic, and polycyclic aromatic hydrocarbon exposure and risk of chronic bronchitis in the US adult population. Environ Sci Pollut Res Int 2022. [PMID: 35624372 DOI: 10.1007/s11356-022-20982-9] [Reference Citation Analysis]
19 Zhang X, Ding K, Miao X, Wang J, Hu B, Shen J, Hu X, Xu Y, Yu B, Tu T, Lin A, Chen X, Huang Y. Associations between bone mineral density and chronic obstructive pulmonary disease. J Int Med Res 2022;50:3000605221094644. [PMID: 35579181 DOI: 10.1177/03000605221094644] [Reference Citation Analysis]
20 Sathiavageesan S, Sundaram V, Sundaram N, Shanmugam VB, Selvaraj J, Vivek N, Ravi GK, Velan M, Palaniappan C, Singaravelu V, Shanmugam MP. Fulminant onset COVID-19: predictors and outcome. Postgrad Med J 2022:postgradmedj-2022-141724. [PMID: 35537807 DOI: 10.1136/postgradmedj-2022-141724] [Reference Citation Analysis]
21 Klijnhout J, Mannée D, van den Heuvel M, van den Borst B, van Helvoort H. Patients with Chronic Obstructive Pulmonary Disease Can Accurately Perform Home-Based Measurements of Inspiratory Capacity and Dynamic Hyperinflation. COPD 2022;19:236-42. [PMID: 35535918 DOI: 10.1080/15412555.2022.2069554] [Reference Citation Analysis]
22 da Luz Goulart C, Oliveira MR, Sendín FA, Mendes RG, Arena R, Borghi-Silva A. Prognostic value of key variables from cardiopulmonary exercise testing in patients with COPD: 42-month follow-up. Respir Med 2022;197:106856. [PMID: 35461168 DOI: 10.1016/j.rmed.2022.106856] [Reference Citation Analysis]
23 Gomez N, James V, Onion D, Fairclough LC. Extracellular vesicles and chronic obstructive pulmonary disease (COPD): a systematic review. Respir Res 2022;23:82. [PMID: 35382831 DOI: 10.1186/s12931-022-01984-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
24 Jing J, Xu D, Li Z, Wang J, Dai J, Li F. Genetic variation of six specific SNPs of chronic obstructive pulmonary disease among Chinese population. Pulmonology 2022. [DOI: 10.1016/j.pulmoe.2022.02.004] [Reference Citation Analysis]
25 Wang GD, Li Q, Han YT, Zhang T. A prospective study on clinical effect and immune regulation on cytokines secreted by Th cells of aerosolized Traditional Chinese Medicine on elderly patients with AECOPD. Phytomedicine Plus 2022. [DOI: 10.1016/j.phyplu.2022.100282] [Reference Citation Analysis]
26 Martínez-Luna N, Orea-Tejeda A, González-Islas D, Flores-Cisneros L, Keirns-Davis C, Sánchez-Santillán R, Pérez-García I, Gastelum-Ayala Y, Martínez-Vázquez V, Martínez-Reyna Ó. Association between body composition, sarcopenia and pulmonary function in chronic obstructive pulmonary disease. BMC Pulm Med 2022;22:106. [PMID: 35346135 DOI: 10.1186/s12890-022-01907-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Zhang X, Miao X, Ding K, Wang J, Hu B, Hu X, Shen J, Liu C, Xu Y, Zhao X, Bao L, Chen W, Zhang B, Huang Y, Stankovic S. The Relationship of Partial Pressure of Carbon Dioxide (PaCO2) with Disease Severity Indicators Such as BODE and GOLD in Hospitalized COPD Patients. International Journal of Clinical Practice 2022;2022:1-8. [DOI: 10.1155/2022/4205079] [Reference Citation Analysis]
28 Zhu D, Qiao C, Dai H, Hu Y, Xi Q. Diagnostic efficacy of visual subtypes and low attenuation area based on HRCT in the diagnosis of COPD. BMC Pulm Med 2022;22. [DOI: 10.1186/s12890-022-01875-6] [Reference Citation Analysis]
29 Chen L, Zhu D, Huang J, Zhang H, Zhou G, Zhong X. Identification of Hub Genes Associated with COPD Through Integrated Bioinformatics Analysis. COPD 2022;Volume 17:439-56. [DOI: 10.2147/copd.s353765] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Mannino D, Bogart M, Germain G, Huang SP, Ismaila AS, Laliberté F, Jung Y, Macknight SD, Stiegler MA, Duh MS. Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation. COPD 2022;Volume 17:491-504. [DOI: 10.2147/copd.s337668] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Rahman HH, Niemann D, Munson-McGee SH. Urinary Metals, Arsenic, and Polycyclic Aromatic Hydrocarbon Exposure and Risk of Self-reported Emphysema in the US Adult Population. Lung 2022. [PMID: 35178625 DOI: 10.1007/s00408-022-00518-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Altintas Dogan AD, Hilberg O, Hess S, Jensen TT, Bladbjerg E, Juhl CB. Respiratory Effects of Treatment with a Glucagon-Like Peptide-1 Receptor Agonist in Patients Suffering from Obesity and Chronic Obstructive Pulmonary Disease. COPD 2022;Volume 17:405-14. [DOI: 10.2147/copd.s350133] [Reference Citation Analysis]
33 Orea-Tejeda A, Gómez-Martínez M, González-Islas D, Flores-Cisneros L, Keirns-Davis C, Sánchez-Santillán R, Pérez-García I, Martínez-Luna N, Robles-Hernández R, Sánchez-Moreno C, Orozco-Gutíerrez JJ. The impact of hydration status and fluid distribution on pulmonary function in COPD patients. Sci Rep 2022;12:1216. [PMID: 35075255 DOI: 10.1038/s41598-022-05192-0] [Reference Citation Analysis]
34 Mo R, Zhang J, Chen Y, Ding Y. Nicotine promotes chronic obstructive pulmonary disease via inducing pyroptosis activation in bronchial epithelial cells. Mol Med Rep 2022;25:92. [PMID: 35059736 DOI: 10.3892/mmr.2022.12608] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Wu H, Ma H, Wang L, Zhang H, Lu L, Xiao T, Cheng C, Wang P, Yang Y, Wu M, Wang S, Zhang J, Liu Q. Regulation of lung epithelial cell senescence in smoking-induced COPD/emphysema by microR-125a-5p via Sp1 mediation of SIRT1/HIF-1a. Int J Biol Sci 2022;18:661-74. [PMID: 35002516 DOI: 10.7150/ijbs.65861] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
36 Zhou J, Zhang J, Zhou M, Hang J, Zhang M, Han F, Zhu H. The role of long-acting muscarinic antagonist/long-acting β agonist fixed-dose combination treatment for chronic obstructive pulmonary disease in China: a narrative review. J Thorac Dis 2021;13:6453-67. [PMID: 34992824 DOI: 10.21037/jtd-21-961] [Reference Citation Analysis]
37 Lampignano L, Donghia R, Sila A, Bortone I, Tatoli R, De Nucci S, Castellana F, Zupo R, Tirelli S, Giannoccaro V, Guerra V, Panza F, Lozupone M, Mastronardi M, De Pergola G, Giannelli G, Sardone R. Mediterranean Diet and Fatty Liver Risk in a Population of Overweight Older Italians: A Propensity Score-Matched Case-Cohort Study. Nutrients 2022;14:258. [PMID: 35057439 DOI: 10.3390/nu14020258] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Fan Z, Zhou B, Liu Y, Sun W, Fang Y, Lu H, Chen D, Lu K, Wu X, Xiao T, Xie W, Bian Q. Optimization and Application of an Efficient and Stable Inhalation Exposure System for Rodents. AAPS PharmSciTech 2022;23:50. [PMID: 34993683 DOI: 10.1208/s12249-021-02191-8] [Reference Citation Analysis]
39 Wang Y, Su T, Feng S, Chen J, Tian X, Zhu L. Evaluation of the cross-sectional area of small pulmonary vessels in the diagnosis of chronic obstructive pulmonary disease by quantitative computed tomography: A case-control study. Medicine (Baltimore) 2021;100:e27622. [PMID: 34797285 DOI: 10.1097/MD.0000000000027622] [Reference Citation Analysis]
40 Otake S, Chubachi S, Nakayama S, Sakurai K, Irie H, Hashiguchi M, Itabashi Y, Yamada Y, Jinzaki M, Murata M, Nakamura H, Asano K, Fukunaga K. Clinical Utility of the Electrocardiographic P-Wave Axis in Patients with Chronic Obstructive Pulmonary Disease. Respiration 2021;:1-8. [PMID: 34784604 DOI: 10.1159/000519668] [Reference Citation Analysis]
41 Lee CT, Chien JY, Hsu MJ, Wu HD, Wang LY. Inspiratory muscle activation during inspiratory muscle training in patients with COPD. Respir Med 2021;190:106676. [PMID: 34773734 DOI: 10.1016/j.rmed.2021.106676] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Yu H, Guo W, Liu Y, Wang Y. Immune Characteristics Analysis and Transcriptional Regulation Prediction Based on Gene Signatures of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2021;16:3027-39. [PMID: 34764646 DOI: 10.2147/COPD.S325328] [Reference Citation Analysis]
43 Sahasrabudhe SD, Orme MW, Jones AV, Tillu G, Salvi SS, Singh SJ. Potential for integrating yoga within pulmonary rehabilitation and recommendations of reporting framework. BMJ Open Respir Res 2021;8:e000966. [PMID: 34764198 DOI: 10.1136/bmjresp-2021-000966] [Reference Citation Analysis]
44 Reuss JE, Brigham E, Psoter KJ, Voong KR, Shankar B, Ettinger DS, Marrone KA, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, Hales RK, D'Alessio F, Danoff SK, Forde PM, Suresh K, Naidoo J. Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC. JTO Clin Res Rep 2021;2:100220. [PMID: 34746881 DOI: 10.1016/j.jtocrr.2021.100220] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Ding Q, Wei X, Li J, Gao YZ, Xu SD, Yu N, Mi JY, Mi BB, Guo YM. Role of the Emphysema Index Combined with the Chronic Obstructive Pulmonary Disease Assessment Test Score in the Evaluation of Chronic Obstructive Pulmonary Disease. Can Respir J 2021;2021:9996305. [PMID: 34691315 DOI: 10.1155/2021/9996305] [Reference Citation Analysis]
46 Zhu X, Zhan Y, Gu Y, Huang Q, Wang T, Deng Z, Xie J. Cigarette Smoke Promotes Interleukin-8 Production in Alveolar Macrophages Through the Reactive Oxygen Species/Stromal Interaction Molecule 1/Ca2+ Axis. Front Physiol 2021;12:733650. [PMID: 34690806 DOI: 10.3389/fphys.2021.733650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Qaisar R, Ustrana S, Muhammad T, Shah I. Sarcopenia in pulmonary diseases is associated with elevated sarcoplasmic reticulum stress and myonuclear disorganization. Histochem Cell Biol 2021. [PMID: 34665327 DOI: 10.1007/s00418-021-02043-3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
48 Husain MO, Chaudhry IB, Blakemore A, Shakoor S, Husain MA, Lane S, Kiran T, Jafri F, Memon R, Panagioti M, Husain N. Prevalence of depression and anxiety in patients with chronic obstructive pulmonary disease and their association with psychosocial outcomes: A cross-sectional study from Pakistan. SAGE Open Med 2021;9:20503121211032813. [PMID: 34659761 DOI: 10.1177/20503121211032813] [Reference Citation Analysis]
49 Chen L, Chen S. Prediction of readmission in patients with acute exacerbation of chronic obstructive pulmonary disease within one year after treatment and discharge. BMC Pulm Med 2021;21:320. [PMID: 34654406 DOI: 10.1186/s12890-021-01692-3] [Reference Citation Analysis]
50 Hou J, Wang J, Meng J, Zhang X, Niu Y, Gao J, Bai Y, Zhou J. Zanthoxylum bungeanum Seed Oil Attenuates LPS-Induced BEAS-2B Cell Activation and Inflammation by Inhibiting the TLR4/MyD88/NF-κB Signaling Pathway. Evid Based Complement Alternat Med 2021;2021:2073296. [PMID: 34603465 DOI: 10.1155/2021/2073296] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
51 Abia-Trujillo D, Yu Lee-Mateus A, Garcia-Saucedo JC, Saifi O, Patel NM, Herth FJF, Woytanowski JR, Alshelli I, Alevas S, Uribe Becerra JP, Majid A, Edell ES, Dulohery-Scrodin MM, Reisenauer JS, Mehta HJ, Jantz MA, Abbas HK, Fernandez-Bussy S. Prevention of acute exacerbation of chronic obstructive pulmonary disease after bronchoscopic lung volume reduction with endobronchial valves. Clin Respir J 2021. [PMID: 34605606 DOI: 10.1111/crj.13450] [Reference Citation Analysis]
52 Jin R, Zheng Y, Gao T, Zhang Y, Wang B, Hang J, Li H. A nomogram for preoperative prediction of prolonged air leak after pulmonary malignancy resection. Transl Lung Cancer Res 2021;10:3616-26. [PMID: 34584861 DOI: 10.21037/tlcr-21-186] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Mahassine G, Vargas T, Rito R, Lopes D, Pereira ÂM. Relationships between respiratory parameters and quadriceps strength in subjects with chronic obstructive pulmonary disease. Annals of Medicine 2021;53:S152-S152. [DOI: 10.1080/07853890.2021.1896688] [Reference Citation Analysis]
54 Karim A, Muhammad T, Qaisar R. Prediction of Sarcopenia Using Multiple Biomarkers of Neuromuscular Junction Degeneration in Chronic Obstructive Pulmonary Disease. J Pers Med 2021;11:919. [PMID: 34575696 DOI: 10.3390/jpm11090919] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
55 Sarkar S, Bhattacharya J. CHRONIC OBSTRUCTIVE PULMONARY DISEASE: GRADING OF SEVERITY AS REFLECTED BY SHORT TERM HEART RATE VARIABILITY. ijsr. [DOI: 10.36106/ijsr/8431417] [Reference Citation Analysis]
56 Tomchaney M, Contoli M, Mayo J, Baraldo S, Li S, Cabel CR, Bull DA, Lick S, Malo J, Knoper S, Kim SS, Tram J, Rojas-Quintero J, Kraft M, Ledford JG, Tesfaigzi Y, Martinez FD, Thorne CA, Kheradmand F, Campos SK, Papi A, Polverino F. Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and disease. BMC Pulm Med 2021;21:275. [PMID: 34425811 DOI: 10.1186/s12890-021-01639-8] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
57 Yu J, Lee MR, Chen CT, Lin YT, How CK. Predictors of Successful Weaning from Noninvasive Ventilation in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Single-Center Retrospective Cohort Study. Lung 2021;199:457-66. [PMID: 34420091 DOI: 10.1007/s00408-021-00469-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Chen H, Li P, Li N, Wang Z, Wu W, Wang J. Rehabilitation effects of land and water-based aerobic exercise on lung function, dyspnea, and exercise capacity in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e26976. [PMID: 34414971 DOI: 10.1097/MD.0000000000026976] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
59 Brighton LJ, Bristowe K, Bayly J, Ogden M, Farquhar M, Evans CJ, Man WDC, Maddocks M. Experiences of Pulmonary Rehabilitation in People Living with Chronic Obstructive Pulmonary Disease and Frailty. A Qualitative Interview Study. Ann Am Thorac Soc 2020;17:1213-21. [PMID: 32644823 DOI: 10.1513/AnnalsATS.201910-800OC] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
60 Sami R, Salehi K, Hashemi M, Atashi V. Exploring the barriers to pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: a qualitative study. BMC Health Serv Res 2021;21:828. [PMID: 34404393 DOI: 10.1186/s12913-021-06814-5] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
61 Xiong J, Le Y, Rao Y, Zhou L, Hu Y, Guo S, Sun Y. RANKL Mediates Muscle Atrophy and Dysfunction in a Cigarette Smoke-induced Model of Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol 2021;64:617-28. [PMID: 33689672 DOI: 10.1165/rcmb.2020-0449OC] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
62 Adhikari TB, Neupane D, Karki A, Drews A, Cooper B, Högman M, Sigsgaard T, Kallestrup P. Community-based intervention for prevention and management of chronic obstructive pulmonary disease in Nepal (COBIN-P trial): study protocol for a cluster-randomized controlled trial. Trials 2021;22:474. [PMID: 34289879 DOI: 10.1186/s13063-021-05447-7] [Reference Citation Analysis]
63 Kim T, Kang J. Association between dual use of e-cigarette and cigarette and chronic obstructive pulmonary disease: an analysis of a nationwide representative sample from 2013 to 2018. BMC Pulm Med 2021;21:231. [PMID: 34256746 DOI: 10.1186/s12890-021-01590-8] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
64 Tzanakis N, Koulouris N, Dimakou K, Gourgoulianis K, Kosmas E, Chasapidou G, Konstantinidis A, Kyriakopoulos C, Kontakiotis T, Rapti A, Gaga M, Kalafatakis K, Kostikas K. Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study. BMC Pulm Med 2021;21:216. [PMID: 34243744 DOI: 10.1186/s12890-021-01576-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Pu X, Liu L, Feng B, Zhang Z, Wang G. Association between ICS use and risk of hyperglycemia in COPD patients: systematic review and meta-analysis. Respir Res 2021;22:201. [PMID: 34238280 DOI: 10.1186/s12931-021-01789-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Patel JC, Singh A, Tulswani R, Sharma YK, Khurana P, Ragumani S. Identification of VEGFA-centric temporal hypoxia-responsive dynamic cardiopulmonary network biomarkers. Life Sci 2021;281:119718. [PMID: 34147483 DOI: 10.1016/j.lfs.2021.119718] [Reference Citation Analysis]
67 Li M, Cheng K, Ku K, Li J, Hu H, Ung COL. Factors Influencing the Length of Hospital Stay Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in Macao Population: A Retrospective Study of Inpatient Health Record. Int J Chron Obstruct Pulmon Dis 2021;16:1677-85. [PMID: 34135579 DOI: 10.2147/COPD.S307164] [Reference Citation Analysis]
68 Fischer T, Winter I, Drumm R, Schneider M. Cylindrical Microparticles Composed of Mesoporous Silica Nanoparticles for the Targeted Delivery of a Small Molecule and a Macromolecular Drug to the Lungs: Exemplified with Curcumin and siRNA. Pharmaceutics 2021;13:844. [PMID: 34200405 DOI: 10.3390/pharmaceutics13060844] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Lee EG, Rhee CK. Epidemiology, burden, and policy of chronic obstructive pulmonary disease in South Korea: a narrative review. J Thorac Dis 2021;13:3888-97. [PMID: 34277078 DOI: 10.21037/jtd-20-2100] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Hartford W, Asgarova S, MacDonald G, Berger M, Cristancho S, Nimmon L. Macro and meso level influences on distributed integrated COPD care delivery: a social network perspective. BMC Health Serv Res 2021;21:491. [PMID: 34024272 DOI: 10.1186/s12913-021-06532-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Jasper AE, Sapey E, Thickett DR, Scott A. Understanding potential mechanisms of harm: the drivers of electronic cigarette-induced changes in alveolar macrophages, neutrophils, and lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2021;321:L336-48. [PMID: 34009037 DOI: 10.1152/ajplung.00081.2021] [Reference Citation Analysis]
72 Kim DJ, Oh JY, Rhee CK, Park SJ, Shim JJ, Cho JY. Metabolic Fingerprinting Uncovers the Distinction Between the Phenotypes of Tuberculosis Associated COPD and Smoking-Induced COPD. Front Med (Lausanne) 2021;8:619077. [PMID: 34055821 DOI: 10.3389/fmed.2021.619077] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Kalra MK, Ebrahimian S. Quantitative Chest CT in COPD: Can Deep Learning Enable the Transition? Radiol Cardiothorac Imaging 2021;3:e210044. [PMID: 33970150 DOI: 10.1148/ryct.2021210044] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
74 She W, Jia S, Hua Y, Feng X, Xing Y, She W, Zhang J, Liao J. The effect of nitrogen dioxide and atmospheric pressure on hospitalization risk for chronic obstructive pulmonary disease in Guangzhou, China. Respir Med 2021;182:106424. [PMID: 33932714 DOI: 10.1016/j.rmed.2021.106424] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Qaisar R, Karim A, Muhammad T, Shah I, Khan J. Prediction of sarcopenia using a battery of circulating biomarkers. Sci Rep 2021;11:8632. [PMID: 33883602 DOI: 10.1038/s41598-021-87974-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
76 Li W, Meng X, Hao Y, Chen M, Jia Y, Gao P. Elevated sputum IL-36 levels are associated with neutrophil-related inflammation in COPD patients. Clin Respir J 2021;15:648-56. [PMID: 33559376 DOI: 10.1111/crj.13338] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
77 Lin HL, Fink JB, Ge H. Aerosol delivery via invasive ventilation: a narrative review. Ann Transl Med 2021;9:588. [PMID: 33987286 DOI: 10.21037/atm-20-5665] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
78 Song X, Hallensleben C, Zhang W, Jiang Z, Shen H, Gobbens RJJ, Kleij RMJJV, Chavannes NH, Versluis A. Blended Self-Management Interventions to Reduce Disease Burden in Patients With Chronic Obstructive Pulmonary Disease and Asthma: Systematic Review and Meta-analysis. J Med Internet Res 2021;23:e24602. [PMID: 33788700 DOI: 10.2196/24602] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
79 Cui H, Liu X, Zhang J, Zhang K, Yao D, Dong S, Feng S, Yang L, Li Y, Wang H, Huang J, Wang J. Rhodiola rosea L. Attenuates Cigarette Smoke and Lipopolysaccharide-Induced COPD in Rats via Inflammation Inhibition and Antioxidant and Antifibrosis Pathways. Evid Based Complement Alternat Med 2021;2021:6103158. [PMID: 33747104 DOI: 10.1155/2021/6103158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
80 Zheng L, Jiang YL, Fei J, Cao P, Zhang C, Xie GF, Wang LX, Cao W, Fu L, Zhao H. Circulatory cadmium positively correlates with epithelial-mesenchymal transition in patients with chronic obstructive pulmonary disease. Ecotoxicol Environ Saf 2021;215:112164. [PMID: 33756289 DOI: 10.1016/j.ecoenv.2021.112164] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
81 Nambiar S, Tan DBA, Clynick B, Bong SH, Rawlinson C, Gummer J, Corte TJ, Glaspole I, Moodley YP, Trengove R. Untargeted metabolomics of human plasma reveal lipid markers unique to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Proteomics Clin Appl 2021;15:e2000039. [PMID: 33580915 DOI: 10.1002/prca.202000039] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
82 Zhang XF, Xiang SY, Lu J, Li Y, Zhao SJ, Jiang CW, Liu XG, Liu ZB, Zhang J. Electroacupuncture inhibits IL-17/IL-17R and post-receptor MAPK signaling pathways in a rat model of chronic obstructive pulmonary disease. Acupunct Med 2021;39:663-72. [PMID: 33715422 DOI: 10.1177/0964528421996720] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
83 Song W, Wang Y, Tian F, Ge L, Shang X, Zeng Q, Feng N, Fan J, Wang J, Ma X. Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Dis Markers 2021;2021:8879401. [PMID: 33791046 DOI: 10.1155/2021/8879401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Wang Y, Li Z, Li FS. Development and Assessment of Prediction Models for the Development of COPD in a Typical Rural Area in Northwest China. Int J Chron Obstruct Pulmon Dis 2021;16:477-86. [PMID: 33664570 DOI: 10.2147/COPD.S297380] [Reference Citation Analysis]
85 Wang JH, Chen RD, Yang HK, Zeng LC, Chen H, Hou YY, Hu W, Yu JS, Li H. Inflammation-associated factors for predicting in-hospital mortality in patients with COVID-19. J Med Virol 2021;93:2908-17. [PMID: 33393678 DOI: 10.1002/jmv.26771] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
86 Xu JH, Wu ZZ, Tao FY, Zhu ST, Chen SP, Cai C, Liang ZH, Shi BB, Chen B, Xie YP. Ultrasound Shear Wave Elastography for Evaluation of Diaphragm Stiffness in Patients with Stable COPD: A Pilot Trial. J Ultrasound Med 2021. [PMID: 33615538 DOI: 10.1002/jum.15655] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
87 Porto EF, Clares S, Ferracioli AM, de Sousa MR, de Oliveira Leite JR, Malheiros RT, De Castro AA. Influence of Lung Hyperinflation on Respiratory Muscles Pressures During a Submaximal Test in Patients With COPD: A Clinical Perspective. CRMR 2021;16:201-6. [DOI: 10.2174/1573398x16999201026222938] [Reference Citation Analysis]
88 Huang Y, Ma J, Jiang B, Yang N, Fu F, Chen X, Liu C, Miao X, Mao H, Zheng R, Wang J, Ding K, Zhang X. Effect of nutritional risk on cognitive function in patients with chronic obstructive pulmonary disease. J Int Med Res 2021;49:300060521990127. [PMID: 33535842 DOI: 10.1177/0300060521990127] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
89 Bi J, Yang W, Hao P, Zhao Y, Wei D, Sun Y, Lin Y, Sun M, Chen X, Luo X, Li S, Zhang W, Wang X. WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial. JMIR Mhealth Uhealth 2021;9:e23548. [PMID: 33528369 DOI: 10.2196/23548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
90 Jiang Z, Zhang Y, Zhu Y, Li C, Zhou L, Li X, Zhang F, Qiu X, Qu Y. Cathelicidin induces epithelial-mesenchymal transition to promote airway remodeling in smoking-related chronic obstructive pulmonary disease. Ann Transl Med 2021;9:223. [PMID: 33708850 DOI: 10.21037/atm-20-2196] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
91 Song J, Zeng M, Wang H, Qin C, Hou HY, Sun ZY, Xu SP, Wang GP, Guo CL, Deng YK, Wang ZC, Ma J, Pan L, Liao B, Du ZH, Feng QM, Liu Y, Xie JG, Liu Z. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19. Allergy 2021;76:483-96. [PMID: 32716553 DOI: 10.1111/all.14517] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 64.0] [Reference Citation Analysis]
92 Montserrat-Capdevila J, Marsal JR, Ortega M, Castañ-Abad MT, Alsedà M, Barbé F, Godoy P. Clinico-epidemiological characteristics of men and women with a new diagnosis of chronic obstructive pulmonary disease: a database (SIDIAP) study. BMC Pulm Med 2021;21:44. [PMID: 33509131 DOI: 10.1186/s12890-021-01392-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
93 Ciarametaro M, Houghton K, Wamble D, Dubois R. The Dollar or Disease Burden: Caps on Healthcare Spending May Save Money, but at What "Cost" to Patients? Value Health 2021;24:388-96. [PMID: 33641773 DOI: 10.1016/j.jval.2020.10.024] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
94 Castellana F, Lampignano L, Bortone I, Zupo R, Lozupone M, Griseta C, Daniele A, De Pergola G, Giannelli G, Sardone R, Panza F. Physical Frailty, Multimorbidity, and All-Cause Mortality in an Older Population From Southern Italy: Results from the Salus in Apulia Study. J Am Med Dir Assoc 2021;22:598-605. [PMID: 33493467 DOI: 10.1016/j.jamda.2020.12.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
95 Lee SC, An C, Yoo J, Park S, Shin D, Han CH. Development and validation of a nomogram to predict pulmonary function and the presence of chronic obstructive pulmonary disease in a Korean population. BMC Pulm Med 2021;21:32. [PMID: 33468128 DOI: 10.1186/s12890-021-01391-z] [Reference Citation Analysis]
96 Zhang MY, Jiang YX, Yang YC, Liu JY, Huo C, Ji XL, Qu YQ. Cigarette smoke extract induces pyroptosis in human bronchial epithelial cells through the ROS/NLRP3/caspase-1 pathway. Life Sci 2021;269:119090. [PMID: 33465393 DOI: 10.1016/j.lfs.2021.119090] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
97 Zhong W, Zhang X, Zeng Y, Lin D, Wu J. Recent applications and strategies in nanotechnology for lung diseases. Nano Res 2021;:1-23. [PMID: 33456721 DOI: 10.1007/s12274-020-3180-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
98 Lv MY, Qiang LX, Li ZH, Jin SD. The lower the eosinophils, the stronger the inflammatory response? The relationship of different levels of eosinophils with the degree of inflammation in acute exacerbation chronic obstructive pulmonary disease (AECOPD). J Thorac Dis 2021;13:232-43. [PMID: 33569203 DOI: 10.21037/jtd-20-2178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
99 Theodorakis SG, Kolios G, Tzilas V, Bouros D. Influence of inhalation device, active substance, and drug formulation on the compliance of patients with obstructive pulmonary diseases. A physicians' perspective. Pulmonology 2020:S2531-0437(20)30255-5. [PMID: 33388297 DOI: 10.1016/j.pulmoe.2020.11.008] [Reference Citation Analysis]
100 Tan J, Li L, Huang X, Yang C, Liang X, Zhao Y, Xie J, Chen R, Wang D, Xie S. Associations between gastro-oesophageal reflux disease and a range of diseases: an umbrella review of systematic reviews and meta-analyses. BMJ Open 2020;10:e038450. [PMID: 33380477 DOI: 10.1136/bmjopen-2020-038450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
101 Zhu J, Ma C, Dai X, Wang Z, Fan H, Feng Z, Luo Y, Zhang Y, Hu F. Outcomes of single physician-modified fenestrated stent grafts for endovascular repair of thoracic aortic lesions involving the distal aortic arch. Interact Cardiovasc Thorac Surg 2021;32:560-5. [PMID: 33319231 DOI: 10.1093/icvts/ivaa295] [Reference Citation Analysis]
102 Shehata IM, Elhassan A, Urits I, Viswanath O, Seoane L, Shappley C, Kaye AD. Postoperative Management of Hyperinflated Native Lung in Single-Lung Transplant Recipients with Chronic Obstructive Pulmonary Disease: A Review Article. Pulm Ther. 2021;7:37-46. [PMID: 33263926 DOI: 10.1007/s41030-020-00141-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
103 Huang Y, Jiang B, Miao X, Ma J, Wang J, Ding K, Chen X, Hu Q, Fu F, Zeng T, Hu J, Hu B, Yang D, Zhang X. The Relationship of Lymphocyte to High-Density Lipoprotein Ratio with Pulmonary Function in COPD. Int J Chron Obstruct Pulmon Dis 2020;15:3159-69. [PMID: 33293805 DOI: 10.2147/COPD.S276372] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
104 Zarrin PS, Zahari F, Mahadevaiah MK, Perez E, Kohlstedt H, Wenger C. Neuromorphic on-chip recognition of saliva samples of COPD and healthy controls using memristive devices. Sci Rep 2020;10:19742. [PMID: 33184439 DOI: 10.1038/s41598-020-76823-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
105 Hirakawa Y, Hirahara S, Yamaguchi Y, Yamanaka T, Arai H, Miura H. Improving the quality of community primary palliative care in COPD: A qualitative study of health-care providers. Home Health Care Serv Q 2021;40:39-53. [PMID: 33156734 DOI: 10.1080/01621424.2020.1845272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
106 Zheng H, Hu Y, Dong L, Shu Q, Zhu M, Li Y, Chen C, Gao H, Yang L. Predictive diagnosis of chronic obstructive pulmonary disease using serum metabolic biomarkers and least-squares support vector machine. J Clin Lab Anal 2021;35:e23641. [PMID: 33141993 DOI: 10.1002/jcla.23641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
107 Shen M, Li Y, Ding X, Xu L, Li F, Lin H. Effect of active cycle of breathing techniques in patients with chronic obstructive pulmonary disease: a systematic review of intervention. Eur J Phys Rehabil Med 2020;56. [DOI: 10.23736/s1973-9087.20.06144-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Shi H, Xu J, Feng Q, Sun J, Yang Y, Zhao J, Zhou X, Niu H, He P, Liu J, Li Q, Ding Y. The effect of CYP3A4 genetic variants on the susceptibility to chronic obstructive pulmonary disease in the Hainan Han population. Genomics 2020;112:4399-405. [DOI: 10.1016/j.ygeno.2020.07.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 Zhang Y, Chen C, Hu J, Han Y, Huang M, Xiang J, Li H. Early outcomes of robotic versus thoracoscopic segmentectomy for early-stage lung cancer: A multi-institutional propensity score-matched analysis. The Journal of Thoracic and Cardiovascular Surgery 2020;160:1363-72. [DOI: 10.1016/j.jtcvs.2019.12.112] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
110 Lozupone M, Sardone R, Donghia R, D'Urso F, Piccininni C, Battista P, Di Gioia I, Resta E, Castellana F, Lampignano L, Zupo R, Bortone I, Guerra V, Griseta C, Seripa D, Solfrizzi V, Giannelli G, Quaranta N, Logroscino G, Bellomo A, Panza F. Late-onset depression is associated to age-related central auditory processing disorder in an older population in Southern Italy. Geroscience 2021;43:1003-14. [PMID: 33128133 DOI: 10.1007/s11357-020-00290-1] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
111 Nurfitria HA, Syafa’ah S, Adriyani R. Determinant Factor of Pulmonary Function Impairment on Rice Mill Workers. JKL 2020;12:262. [DOI: 10.20473/jkl.v12i4.2020.262-269] [Reference Citation Analysis]
112 Pezzuto A, Tammaro A, Tonini G, Ciccozzi M. COPD influences survival in patients affected by COVID-19, comparison between subjects admitted to an internal medicine unit, and subjects admitted to an intensive care unit: An Italian experience. J Med Virol 2021;93:1239-41. [PMID: 33026657 DOI: 10.1002/jmv.26585] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
113 Xie L, Liu Z, Hao S, Wu Q, Sun L, Luo H, Yu R, Li X, Wu X, Li S. Assessment of knowledge, attitude, and practice towards pulmonary rehabilitation among COPD patients: A multicenter and cross-sectional survey in China. Respir Med 2020;174:106198. [PMID: 33120194 DOI: 10.1016/j.rmed.2020.106198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
114 Qaisar R, Karim A, Muhammad T, Shah I. Circulating Biomarkers of Accelerated Sarcopenia in Respiratory Diseases. Biology (Basel) 2020;9:E322. [PMID: 33023021 DOI: 10.3390/biology9100322] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
115 Shi H, Tavárez ZQ, Xie Z, Schneller LM, Croft DP, Goniewicz ML, McIntosh S, O'Connor RJ, Ossip DJ, Rahman I, Li D. Association of flavored electronic nicotine delivery system (ENDS) use with self-reported chronic obstructive pulmonary disease (COPD): Results from the Population Assessment of Tobacco and Health (PATH) study, Wave 4. Tob Induc Dis 2020;18:82. [PMID: 33082739 DOI: 10.18332/tid/127238] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
116 Jian T, Chen J, Ding X, Lv H, Li J, Wu Y, Ren B, Tong B, Zuo Y, Su K, Li W. Flavonoids isolated from loquat (Eriobotrya japonica) leaves inhibit oxidative stress and inflammation induced by cigarette smoke in COPD mice: the role of TRPV1 signaling pathways. Food Funct 2020;11:3516-26. [PMID: 32253400 DOI: 10.1039/c9fo02921d] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
117 Hino T, Hata A, Hida T, Yamada Y, Ueyama M, Araki T, Kamitani T, Nishino M, Kurosaki A, Jinzaki M, Ishigami K, Honda H, Hatabu H, Kudoh S. Projected lung areas using dynamic X-ray (DXR). Eur J Radiol Open 2020;7:100263. [PMID: 32953949 DOI: 10.1016/j.ejro.2020.100263] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
118 Al-Azzawi MA, AboZaid MMN, Ibrahem RAL, Sakr MA. Therapeutic effects of black seed oil supplementation on chronic obstructive pulmonary disease patients: A randomized controlled double blind clinical trial. Heliyon 2020;6:e04711. [PMID: 32904114 DOI: 10.1016/j.heliyon.2020.e04711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
119 He Y, Xie M, Zhao J, Liu X. Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD). Med Sci Monit 2020;26:e927212. [PMID: 32883943 DOI: 10.12659/MSM.927212] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
120 Li Z, Luo G, Hu W, Hua J, Geng S, Chu PK, Zhang J, Wang H, Yu X. Mediated Drug Release from Nanovehicles by Black Phosphorus Quantum Dots for Efficient Therapy of Chronic Obstructive Pulmonary Disease. Angew Chem 2020;132:20749-57. [DOI: 10.1002/ange.202008379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
121 Li Z, Luo G, Hu WP, Hua JL, Geng S, Chu PK, Zhang J, Wang H, Yu XF. Mediated Drug Release from Nanovehicles by Black Phosphorus Quantum Dots for Efficient Therapy of Chronic Obstructive Pulmonary Disease. Angew Chem Int Ed Engl 2020;59:20568-76. [PMID: 32666703 DOI: 10.1002/anie.202008379] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
122 Zhang HQ, Lin JY, Guo Y, Pang S, Jiang R, Cheng QJ. Medication adherence among patients with chronic obstructive pulmonary disease treated in a primary general hospital during the COVID-19 pandemic. Ann Transl Med 2020;8:1179. [PMID: 33241028 DOI: 10.21037/atm-20-6016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
123 Albitar HAH, Iyer VN. Adherence to Global Initiative for Chronic Obstructive Lung Disease guidelines in the real world: current understanding, barriers, and solutions. Curr Opin Pulm Med 2020;26:149-54. [PMID: 31834001 DOI: 10.1097/MCP.0000000000000655] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
124 Chen Y, Du S, Zhang Z, He W, Lu E, Wang R, Sha X, Ma Y. Compatible Stability and Aerosol Characteristics of Atrovent® (Ipratropium Bromide) Mixed with Salbutamol Sulfate, Terbutaline Sulfate, Budesonide, and Acetylcysteine. Pharmaceutics 2020;12:E776. [PMID: 32824123 DOI: 10.3390/pharmaceutics12080776] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
125 Yuan L, Li L, Yu T, Yang Z, Jiang T, Ma Q, Qi J, Shi Y, Zhao P. The correlational study about neutrophil-to-lymphocyte ratio and exercise tolerance of chronic obstructive pulmonary disease patients. Medicine (Baltimore) 2020;99:e21550. [PMID: 32872002 DOI: 10.1097/MD.0000000000021550] [Reference Citation Analysis]
126 Nakamaru Y, Suzuki M, Honma A, Nakazono A, Kimura S, Fujiwara K, Morita S, Konno S, Homma A. Preoperative Pulmonary Function Testing to Predict Recurrence of Chronic Rhinosinusitis With Nasal Polyps. Allergy Rhinol (Providence) 2020;11:2152656720946994. [PMID: 32844045 DOI: 10.1177/2152656720946994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
127 Krauss E, Haberer J, Barreto G, Degen M, Seeger W, Guenther A. Recognition of breathprints of lung cancer and chronic obstructive pulmonary disease using the Aeonose® electronic nose. J Breath Res 2020;14:046004. [PMID: 32325432 DOI: 10.1088/1752-7163/ab8c50] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
128 Berner K, Albertyn SCS, Dawnarain S, Hendricks LJ, Johnson J, Landman A, Burger M. The effectiveness of combined lower limb strengthening and whole-body vibration, compared to strengthening alone, for improving patient-centred outcomes in adults with COPD: A systematic review. S Afr J Physiother 2020;76:1412. [PMID: 32671277 DOI: 10.4102/sajp.v76i1.1412] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
129 Qaisar R, Karim A, Muhammad T. Plasma CAF22 Levels as a Useful Predictor of Muscle Health in Patients with Chronic Obstructive Pulmonary Disease. Biology (Basel) 2020;9:E166. [PMID: 32679792 DOI: 10.3390/biology9070166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
130 Schmidt M, Cattani-Cavalieri I, Nuñez FJ, Ostrom RS. Phosphodiesterase isoforms and cAMP compartments in the development of new therapies for obstructive pulmonary diseases. Curr Opin Pharmacol 2020;51:34-42. [PMID: 32622335 DOI: 10.1016/j.coph.2020.05.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
131 Maier C, Trabue J, Farley K, Paz J, Walter A. Rehabilitation interventions to reduce the risk of falls in patients with chronic obstructive pulmonary disease: a systematic review of the literature. Physical Therapy Reviews 2020;25:175-86. [DOI: 10.1080/10833196.2020.1784571] [Reference Citation Analysis]
132 Guo-Parke H, Linden D, Weldon S, Kidney JC, Taggart CC. Mechanisms of Virus-Induced Airway Immunity Dysfunction in the Pathogenesis of COPD Disease, Progression, and Exacerbation. Front Immunol 2020;11:1205. [PMID: 32655557 DOI: 10.3389/fimmu.2020.01205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
133 Park MH, Kim MJ, Kim AJ, Lee MJ, Kim JS. Helmet-based noninvasive ventilation for acute exacerbation of chronic obstructive pulmonary disease: A case report. World J Clin Cases 2020; 8(10): 1939-1943 [PMID: 32518784 DOI: 10.12998/wjcc.v8.i10.1939] [Reference Citation Analysis]
134 Enright P, Fragoso CV. GPs should not try to detect mild COPD. NPJ Prim Care Respir Med 2020;30:20. [PMID: 32393734 DOI: 10.1038/s41533-020-0176-0] [Reference Citation Analysis]
135 Archontogeorgis K, Voulgaris A, Papanas N, Nena E, Xanthoudaki M, Pataka A, Schiza S, Rizzo M, Froudarakis ME, Steiropoulos P. Metabolic Syndrome in Patients with Coexistent Obstructive Sleep Apnea Syndrome and Chronic Obstructive Pulmonary Disease (Overlap Syndrome). Metab Syndr Relat Disord 2020;18:296-301. [PMID: 32379990 DOI: 10.1089/met.2019.0126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
136 Zhao YL, Yang ZF, Wu BF, Shang JH, Liu YP, Wang XH, Luo XD. Indole alkaloids from leaves of Alstonia scholaris (L.) R. Br. protect against emphysema in mice. J Ethnopharmacol 2020;259:112949. [PMID: 32387234 DOI: 10.1016/j.jep.2020.112949] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
137 Terry PD, Dhand R. Inhalation Therapy for Stable COPD: 20 Years of GOLD Reports. Adv Ther 2020;37:1812-28. [PMID: 32246264 DOI: 10.1007/s12325-020-01289-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
138 Maniscalco M, Martucci M, Fuschillo S, de Felice A, D'Anna SE, Cazzola M. A case scenario study on adherence to COPD GOLD recommendations by general practitioners in a rural area of southern Italy: The "progetto PADRE". Respir Med 2020;170:105985. [PMID: 32843161 DOI: 10.1016/j.rmed.2020.105985] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
139 Brighton LJ, Evans CJ, Man WDC, Maddocks M. Improving Exercise-Based Interventions for People Living with Both COPD and Frailty: A Realist Review. Int J Chron Obstruct Pulmon Dis 2020;15:841-55. [PMID: 32368030 DOI: 10.2147/COPD.S238680] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
140 Tung LF, Shen SY, Shih HH, Chen YT, Yen CT, Ho SC. Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study. Respir Res 2020;21:84. [PMID: 32293463 DOI: 10.1186/s12931-020-1328-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
141 Lin YC, Huang CC, Lin MC, Huang ST. Chinese herbal medicine reduces the risk of urinary incontinence in patients with chronic obstructive pulmonary disease: A population-based retrospective cohort study. Int J Urol 2020;27:415-22. [PMID: 32153068 DOI: 10.1111/iju.14211] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
142 Jian T, Ding X, Li J, Wu Y, Ren B, Li J, Lv H, Chen J, Li W. Triterpene Acids of Loquat Leaf Improve Inflammation in Cigarette Smoking Induced COPD by Regulating AMPK/Nrf2 and NFκB Pathways. Nutrients 2020;12:E657. [PMID: 32121228 DOI: 10.3390/nu12030657] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
143 Melbye H, Helgeland J, Karlstad Ø, Ariansen I, Langhammer A, Wisløff T, Nafstad P, Nystad W. Is the Disease Burden from COPD in Norway Falling off? A Study of Time Trends in Three Different Data Sources. Int J Chron Obstruct Pulmon Dis 2020;15:323-34. [PMID: 32103931 DOI: 10.2147/COPD.S235106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
144 Qaisar R, Karim A, Muhammad T. Circulating Biomarkers of Handgrip Strength and Lung Function in Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2020;15:311-21. [PMID: 32103930 DOI: 10.2147/COPD.S225765] [Cited by in Crossref: 6] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
145 Hill NS. No place like home: initiation of non-invasive ventilation for stable severe COPD. Thorax 2020;75:196-7. [PMID: 31996402 DOI: 10.1136/thoraxjnl-2019-213787] [Reference Citation Analysis]
146 Matsuo Y, Ogawa E, Seto-Yukimura R, Ryujin Y, Kinose D, Yamaguchi M, Osawa M, Nagao T, Kurosawa H, Nakano Y. Novel Respiratory Impedance-Based Phenotypes Reflect Different Pathophysiologies in Chronic Obstructive Pulmonary Disease Patients. Int J Chron Obstruct Pulmon Dis 2019;14:2971-7. [PMID: 31908445 DOI: 10.2147/COPD.S224902] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
147 Hallensleben C, Meijer E, Biewenga J, Kievits-smeets RM, Veltman M, Song X, van Boven JF, Chavannes NH. REducing Delay through edUcation on eXacerbations (REDUX) in patients with COPD: a pilot study. Clinical eHealth 2020;3:63-8. [DOI: 10.1016/j.ceh.2020.07.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
148 Liedtke AG, Lava SAG, Milani GP, Agostoni C, Gilardi V, Bianchetti MG, Treglia G, Faré PB. Selective ß2-Adrenoceptor Agonists and Relevant Hyperlactatemia: Systematic Review and Meta-Analysis. J Clin Med 2019;9:E71. [PMID: 31892109 DOI: 10.3390/jcm9010071] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
149 Iyer AS, Goodrich CA, Dransfield MT, Alam SS, Brown CJ, Landefeld CS, Bakitas MA, Brown JR. End-of-Life Spending and Healthcare Utilization Among Older Adults with Chronic Obstructive Pulmonary Disease. Am J Med 2020;133:817-824.e1. [PMID: 31883772 DOI: 10.1016/j.amjmed.2019.11.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
150 Lal C, Khan A. Emerging Treatments for COPD: Evidence to Date on Revefenacin. COPD: Journal of Chronic Obstructive Pulmonary Disease 2020;17:112-9. [DOI: 10.1080/15412555.2019.1702010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
151 Calzetta L, Di Marco F, Blasi F, Cazzola M, Centanni S, Micheletto C, Rossi A, Rogliani P. Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis. Pulmonary Pharmacology & Therapeutics 2019;59:101855. [DOI: 10.1016/j.pupt.2019.101855] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
152 Hlavati M, Buljan K, Tomić S, Horvat M, Butković-Soldo S. Impaired cerebrovascular reactivity in chronic obstructive pulmonary disease. Acta Neurol Belg 2019;119:567-75. [PMID: 31215005 DOI: 10.1007/s13760-019-01170-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
153 Rogers LRK, Verlinde M, Mias GI. Gene expression microarray public dataset reanalysis in chronic obstructive pulmonary disease. PLoS One 2019;14:e0224750. [PMID: 31730674 DOI: 10.1371/journal.pone.0224750] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
154 Vietri L, Fui A, Bergantini L, d'Alessandro M, Cameli P, Sestini P, Rottoli P, Bargagli E. Serum amyloid A: A potential biomarker of lung disorders. Respir Investig 2020;58:21-7. [PMID: 31708467 DOI: 10.1016/j.resinv.2019.09.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
155 Madan A, Turner AM. Identifying the at risk smokers: who goes on to get COPD? Eur Respir J 2019;54:1901613. [PMID: 31672906 DOI: 10.1183/13993003.01613-2019] [Reference Citation Analysis]
156 Iyer AS, Dionne-Odom JN, Khateeb DM, O'Hare L, Tucker RO, Brown CJ, Dransfield MT, Bakitas MA. A Qualitative Study of Pulmonary and Palliative Care Clinician Perspectives on Early Palliative Care in Chronic Obstructive Pulmonary Disease. J Palliat Med 2020;23:513-26. [PMID: 31657654 DOI: 10.1089/jpm.2019.0355] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
157 Pezzuto A, Carico E. Effectiveness of smoking cessation in smokers with COPD and nocturnal oxygen desaturation: Functional analysis. Clin Respir J 2020;14:29-34. [PMID: 31613417 DOI: 10.1111/crj.13096] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
158 Bottasso E. Toward the Existence of a Sympathetic Neuroplasticity Adaptive Mechanism Influencing the Immune Response. A Hypothetical View-Part II. Front Endocrinol (Lausanne) 2019;10:633. [PMID: 31620088 DOI: 10.3389/fendo.2019.00633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
159 Manian P. Chronic obstructive pulmonary disease classification, phenotypes and risk assessment. J Thorac Dis 2019;11:S1761-6. [PMID: 31632753 DOI: 10.21037/jtd.2019.05.10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
160 Kyomoto Y, Asai K, Yamada K, Okamoto A, Watanabe T, Hirata K, Kawaguchi T. Handgrip strength measurement in patients with chronic obstructive pulmonary disease: Possible predictor of exercise capacity. Respiratory Investigation 2019;57:499-505. [DOI: 10.1016/j.resinv.2019.03.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
161 Gong J, Zhao H, Liu T, Li L, Cheng E, Zhi S, Kong L, Yao HW, Li J. Cigarette Smoke Reduces Fatty Acid Catabolism, Leading to Apoptosis in Lung Endothelial Cells: Implication for Pathogenesis of COPD. Front Pharmacol 2019;10:941. [PMID: 31555131 DOI: 10.3389/fphar.2019.00941] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
162 Qin H, Huang G, Gao F, Huang B, Wang D, Hu X, Wang Y, Peng L, Luo D, Mo B, Hu C, Li Y, Wang C. Diminished stimulator of interferon genes production with cigarette smoke-exposure contributes to weakened anti-adenovirus vectors response and destruction of lung in chronic obstructive pulmonary disease model. Exp Cell Res 2019;384:111545. [PMID: 31470016 DOI: 10.1016/j.yexcr.2019.111545] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
163 Qu F, Liu F, Zhang H, Chao L, Guan J, Li R, Yu F, Yan X. The hospitalization attributable burden of acute exacerbations of chronic obstructive pulmonary disease due to ambient air pollution in Shijiazhuang, China. Environ Sci Pollut Res 2019;26:30866-75. [DOI: 10.1007/s11356-019-06244-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
164 Bruderer T, Gaisl T, Gaugg MT, Nowak N, Streckenbach B, Müller S, Moeller A, Kohler M, Zenobi R. On-Line Analysis of Exhaled Breath Focus Review. Chem Rev 2019;119:10803-28. [PMID: 31594311 DOI: 10.1021/acs.chemrev.9b00005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 68] [Article Influence: 12.3] [Reference Citation Analysis]
165 Fens T, van der Pol S, Kocks JWH, Postma MJ, van Boven JFM. Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With Chronic Obstructive Pulmonary Disease: ISPOR's Guidance on Budget Impact in Practice. Value Health 2019;22:1092-101. [PMID: 31563251 DOI: 10.1016/j.jval.2019.05.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
166 Sessa M, Mascolo A, Rasmussen DB, Kragholm K, Jensen MT, Sportiello L, Rafaniello C, Tari GM, Pagliaro C, Andersen M, Rossi F, Capuano A. Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study. Sci Rep 2019;9:11465. [PMID: 31391573 DOI: 10.1038/s41598-019-47967-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
167 Ma J, Tian Y, Li J, Zhang L, Wu M, Zhu L, Liu S. Effect of Bufei Yishen Granules Combined with Electroacupuncture in Rats with Chronic Obstructive Pulmonary Disease via the Regulation of TLR-4/NF-κB Signaling. Evid Based Complement Alternat Med 2019;2019:6708645. [PMID: 31275415 DOI: 10.1155/2019/6708645] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
168 Huang X, Mu X, Deng L, Fu A, Pu E, Tang T, Kong X. The etiologic origins for chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2019;14:1139-58. [PMID: 31213794 DOI: 10.2147/COPD.S203215] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
169 Hao W, Li M, Zhang Y, Zhang C, Xue Y. Expressions of MMP-12, TIMP-4, and Neutrophil Elastase in PBMCs and Exhaled Breath Condensate in Patients with COPD and Their Relationships with Disease Severity and Acute Exacerbations. J Immunol Res 2019;2019:7142438. [PMID: 31143784 DOI: 10.1155/2019/7142438] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
170 Lal C, Strange C. Evaluating fluticasone furoate + vilanterol for the treatment of chronic obstructive pulmonary disease (COPD). Expert Opin Pharmacother 2019;20:1075-85. [PMID: 30983423 DOI: 10.1080/14656566.2019.1603292] [Reference Citation Analysis]
171 Epstein D, Barak-corren Y, Isenberg Y, Berger G. Clinical Decision Support System: A Pragmatic Tool to Improve Acute Exacerbation of COPD Discharge Recommendations. COPD: Journal of Chronic Obstructive Pulmonary Disease 2019;16:18-24. [DOI: 10.1080/15412555.2019.1593342] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
172 Omer S. It's the lungs, not the pump: Chronic obstructive pulmonary disease severity and outcomes after off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg 2019;157:e192-3. [PMID: 33198037 DOI: 10.1016/j.jtcvs.2018.10.123] [Reference Citation Analysis]
173 Rustagi N, Singh S, Dutt N, Kuwal A, Chaudhry K, Shekhar S, Kirubakaran R. Efficacy and Safety of Stent, Valves, Vapour ablation, Coils and Sealant Therapies in Advanced Emphysema: A Meta-Analysis. Turk Thorac J 2019;20:43-60. [PMID: 30664426 DOI: 10.5152/TurkThoracJ.2018.18062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
174 Rodrigues FM, Loeckx M, Hornikx M, Van Remoortel H, Louvaris Z, Demeyer H, Janssens W, Troosters T. Six years progression of exercise capacity in subjects with mild to moderate airflow obstruction, smoking and never smoking controls. PLoS One 2018;13:e0208841. [PMID: 30586370 DOI: 10.1371/journal.pone.0208841] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]